We are live on
!
Find out more
First Trust NYSE Arca Biotechnology Index Fund
305 hedge funds and large institutions have $1.65B invested in First Trust NYSE Arca Biotechnology Index Fund in 2026 Q1 according to their latest regulatory filings, with 57 funds opening new positions, 104 increasing their positions, 73 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
1,148% more call options, than puts
Call options by funds: $4.26M | Put options by funds: $341K
138% more first-time investments, than exits
New positions opened: 57 | Existing positions closed: 24
132% more capital invested
Capital invested by funds: $712M → $1.65B (+$941M)
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
42% more repeat investments, than reductions
Existing positions increased: 104 | Existing positions reduced: 73
19.07% more ownership
Funds ownership: 53.78% → 72.85% (+19%)
10% more funds holding
Funds holding: 278 → 305 (+27)
Holders
305
Holders Change
+27
Holders Change %
+9.71%
% of All Funds
3.76%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.02%
New
57
Increased
104
Reduced
73
Closed
24
Calls
$4.26M
Puts
$341K
Net Calls
+$3.92M
Net Calls Change
+$3.52M
Top Buyers
| 1 |
First Trust Advisors
Wheaton,
Illinois
|
+$726M |
| 2 |
Wells Fargo
San Francisco,
California
|
+$49.2M |
| 3 |
Morgan Stanley
New York
|
+$27.5M |
| 4 |
NP
Nilsine Partners
Greenwood Village,
Colorado
|
+$18.6M |
| 5 |
ASN
Advisory Services Network
Atlanta,
Georgia
|
+$15.6M |
